How RING E3 ligases mediate E2-to-substrate ubiquitin-like protein (UBL) transfer remains unknown. Here we address how the RING E3 RBX1 positions NEDD8's E2 (UBC12) and substrate (CUL1). We find that existing structures are incompatible with CUL1 NEDD8ylation and report a new conformation of RBX1 that places UBC12 adjacent to CUL1. We propose RING domain rotation as a general mechanism for UBL transfer for the largest family of E3s.
NEDD8 to CUL1 (ref. 9) . Here, RBX1's RING binds the NEDD8 E2 UBC12 (also known as UBE2M), and the RBX1-associated CUL1 is the substrate. RBX1 is sufficient as an E3 for NEDD8ylation, although a second E3, DCN1, potentiates this reaction [10] [11] [12] . Second, NEDD8 ligation favors a conformational change that switches on SCF ubiquitin E3 activities [13] [14] [15] . The NEDD8-modified CUL1 assembles with SKP1-F-box protein-substrate, RBX1 binds a ubiquitin-charged E2 such as UBCH5 or CDC34, and ubiquitin is ligated to a substrate 15, 16 . Finally, RBX1 binds another ubiquitin-charged CDC34, and ubiquitin is transferred to Lys48 on a substrate-linked ubiquitin. This final step is repeated in a processive manner to build a Lys48-linked polyubiquitin chain targeting the substrate for 26S proteasomal degradation 17 . Indeed, ~20% of all ubiquitin-proteasomal degradation is estimated to result from E3 activities of NEDD8-activated CRLs 18 . Nonetheless, none of the seven RBX1 structures solved to date has a conformation demonstrating any of its UBL ligase functions 7, 8, 13, 19 .
We set out to understand an active CUL1-RBX1 conformation for the first E3 function of NEDD8ylation. Earlier studies indicated that the canonical E2-binding surface of RBX1's RING recruits UBC12 (ref. 20) . Furthermore, the conventional RING-binding surface of yeast Ubc12 has been implicated in activation by yeast Rbx1 (ref. 12 ). Therefore, we made a model of a CUL1-RBX1-UBC12 complex 1 Fig. 1 ) [2] [3] [4] 7 . We validated the model using mutagenesis and NMR. Mutations designed to disrupt the predicted RBX1-UBC12 interface impaired NEDD8 transfer to CUL1 (Fig. 1a) . Furthermore, titration of RBX1's RING domain into a 15 N-labeled form of UBC12's catalytic domain resulted in chemical shift differences localized primarily to the canonical RING-binding surface ( Fig. 1b,  Supplementary Fig. 1 and Supplementary Table 1 ).
Although valid for RBX1-UBC12 interactions, the CUL1-RBX1-UBC12 model presents a topological problem: a large (~30 Å) gap separates the catalytic Cys111 of UBC12 and the NEDD8 acceptor Lys720 on CUL1 ( Fig. 2a) . To address whether this CUL1-RBX1 conformation is competent for NEDD8 transfer, we generated conformationally restrained disulfide-linked versions of CUL1-RBX1. Because of minor differences among the three published CUL1-RBX1 crystal structures 7, 8 , three closely related sets of cysteine pairs were designed to capitalize on the proximity of CUL1's C terminus to helix-3 of RBX1 ( Supplementary Fig. 2) . The cysteine-pair locations varied by one residue in either CUL1 or RBX1, and all became at least partially disulfide-linked upon exposure of solutions to air overnight. We assayed NEDD8 transfer to CUL1 in either the presence or the absence of the disulfide links between CUL1 and RBX1. CUL1 that was disulfide-linked to RBX1 was not NEDD8ylated. However, under the same conditions, CUL1 was readily modified by NEDD8 in nondisulfide-linked CUL1-RBX1 complexes either remaining after air exposure (for example, pairs B and C) or in reduced samples ( Fig. 2b) . Similar results were also obtained for a complex between RBX1 and CUL1's isolated C-terminal domain (CUL1 CTD ) ( Supplementary  Fig. 2) . Lack of CUL1 NEDD8ylation upon disulfide linking of CUL1 and RBX1 is not due to a defect in RBX1 catalysis of UBC12mediated NEDD8ylation per se, because under the same conditions the disulfide-constrained CUL1~RBX1 (where '~' indicates covalent bonding) complex stimulates NEDD8 transfer from UBC12 to the nonspecific nucleophile hydroxylamine (Supplementary Fig. 3) . Thus, restraining the proximity of CUL1's C-terminal region and RBX1's RING domain impairs NEDD8 transfer specifically to the substrate CUL1. We conclude that (i) the CUL1-RBX1 conformation in existing crystal structures is incompatible with NEDD8ylation, and (ii) it is likely that CUL1, RBX1 or both undergo substantial conformational changes during NEDD8 ligation to CUL1.
We reasoned that cullin-RBX1 complexes are likely to exist in conformations other than those seen previously, and in efforts to observe an alternative form, we obtained a crystal structure of CUL1 CTD in complex with RBX1. The structure reveals a new conformation, apparently favored by this construct under our crystallization conditions, which explains how an RBX1-associated UBC12 can become juxtaposed with CUL1's NEDD8 acceptor Lys720 (Fig. 3, Supplementary  Figs. 4 and 5 and Supplementary Table 2 ). Comparison to previous CUL-RBX1 structures 7, 8, 19 reveals a striking repositioning of the RBX1 RING away from CUL1. The new conformation is achieved by a marked extension of the RBX1 linker between the N-terminal CUL1-binding strand and C-terminal RING involving ~60° rigid-body rotation about a hinge centered at residues Val38 and Val39 ( Fig. 3d and Supplementary Fig. 6 ), a region that we previously speculated, based on much data, would adopt multiple conformations 13 . Superposition of the new CUL1 CTD structure with the corresponding regions of prior CUL1-RBX1 structures also reveals slight relative displacement of the WHB subdomain. This is due to an ~10° tilting at the base of helix-29. Notably, comparison to prior structures of CUL5 CTD -RBX1 and NEDD8~CUL5 CTD -RBX1 revealed that the corresponding hinges undergo dramatic reorientation upon NEDD8 ligation (Supplementary Fig. 6 ) 13 . Thus, although it was not previously observed, it seems likely that our structure exists within the normal range of CUL1-RBX1 conformations.
Docking E2-RING structures 2-4 onto the new CUL1 CTD -RBX1 structure entirely closes the gap between an E2 active site and the CUL1 acceptor Lys720. In fact, if a model is made with UBC12, the gap is slightly over-closed. However, modeling a prior CUL1 structure complexed with the new RBX1 structure places the UBC12 catalytic Cys111 ~3 Å from the ε-amino group of CUL1's NEDD8 acceptor Lys720 (Fig. 3e) .
We tested the model in two ways. First, we introduced individual cysteines into Ubc12 and CUL1 and tested their cross-linking by the homobifunctional sulfhydryl cross-linker bis-maleimidoethane (Supplementary Methods and Fig. 3f ). It was necessary to incorporate individual cysteines into a cysteine-free version of the structurally superimposable Ubc12 from budding yeast 12 because we were unable to express a cysteine-less version of human UBC12. The Ubc12 and CUL1 mutants harboring cysteines predicted by the model to be in close proximity were cross-linked preferentially (Fig. 3f) . Second, we tested in vitro NEDD8ylation by UBC12 mutants with alanine substitutions for Arg116 and Leu145, which are at the predicted interface with CUL1 but have not previously been implicated in UBL transfer (Fig. 3g) . Indeed, the mutants were defective at NEDD8 transfer to CUL1. Furthermore, the relevance of the new RBX1 conformation for CUL1 NEDD8ylation is supported by much prior data. First, in the new structure, the five-residue linker between the N-terminal CUL1binding strand and the C-terminal RING domain extends 15.6 Å (Supplementary Fig. 6 ). If only a single residue were to be deleted, the remaining four residues could span a maximum Cα-to-Cα distance of only 14.4 Å, which would be insufficient for the RING domain to acquire the structurally observed position. Indeed, deletion of one RBX1 residue at the Val38-Val39 hinge almost completely abrogates (a) Structural model of CUL1 CTD -RBX1-UBC12 core (colored light green, pink, cyan, respectively) complex based on previous CUL1-RBX1 and RING-E2 structures [2] [3] [4] 7, 8 ( Supplementary Fig. 1 ). CUL1 NEDD8 modification site and UBC12 catalytic cysteine are indicated by blue and yellow spheres, respectively (next to double arrow). (b) In vitro CUL1 NEDD8ylation assays using disulfide-linked (S~S) and unlinked (SH SH) "split'n'coexpress" CUL1-RBX1 (ref. 7) . +DTT, with dithiothreitol. Pairs A-C refer to three distinct combinations of engineered cysteines ( Supplementary Fig. 2 ). CUL1-NTD, CUL1 N terminus. 13 . Second, assaying CUL1 NEDD8ylation upon proline-scanning mutagenesis of the RBX1 hinge revealed that the most substantial defect was for a V39P mutant, which would restrict rotation about the structurally observed hinge 13 . Notably, the V39P-induced NEDD8ylation defect was rescued by upstream insertion of a single glycine, which would restore the ability of the RBX1 RING domain to be positioned as in our new structure. Finally, the CAND1 NEDD8ylation inhibitor binds the previously observed CUL1-RBX1 interface 8 . Thus, CAND1 may prevent rotation of the RBX1 RING domain to the new, catalytically relevant conformation to inhibit NEDD8ylation. Taken together with previous results, our new data provide the first structural view of a RING E3-substrate complex in a conformation compatible with UBL transfer.
Our disulfide-trapping experiments now show that previously observed closed conformations cannot account for RBX1-mediated NEDD8ylation. Instead, we propose that an active conformation is achieved largely by a striking rotation of the RBX1 RING domain even in the absence of any other factors, reflecting inherent flexibility of RBX1. Although there may be cases where other mechanisms facilitate UBL transfer, it seems likely that many other RING E3s will in the future be found to work similarly, with rotation of RING domains playing major roles in bridging gaps to substrates and mediating UBL ligation. Accession codes. Coordinates and structure factors have been deposited with PDB code 3RTR.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
